Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $1.441B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $615M | 42.7% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Genetron Holdings Ltd | 8,124,174 | $105M | 7.3% | $9.86 | — | ADS | 37186H100 |
| — | Verona Pharma PLC | 4,249,918 | $85.34M | 5.9% | $6.97 | — | ADS | 925050106 |
| HRMY | Harmony Biosciences Holdings Inc | 2,606,247 | $85.09M | 5.9% | $36.16 | +26.0% | Common | 413197104 |
| TERN | Terns Pharmaceuticals Inc | 6,657,992 | $78.83M | 5.5% | $11.36 | -15.9% | Common | 880881107 |
| VRDN | Viridian Therapeutics Inc | 1,678,207 | $42.69M | 3.0% | $15.47 | +107.3% | Common | 92790C104 |
| GERN | Geron Corp | 19,282,834 | $41.84M | 2.9% | $1.35 | +110.2% | Common | 374163103 |
| — | Avadel Pharmaceuticals PLC | 3,761,438 | $34.45M | 2.4% | $8.27 | — | ADR | 05337M104 |
| TARS | Tarsus Pharmaceuticals Inc | 2,262,200 | $28.44M | 2.0% | $28.48 | -48.7% | Common | 87650L103 |
| — | Astria Therapeutics Inc | 1,681,199 | $22.36M | 1.6% | $11.41 | — | Common | 04635X102 |
| PCVX | Vaxcyte Inc | 579,508 | $21.72M | 1.5% | $29.55 | +43.6% | Common | 92243G108 |
| COGT | Cogent Biosciences Inc | 1,994,941 | $21.53M | 1.5% | $8.18 | +56.4% | Common | 19240Q201 |
| — | Chinook Therapeutics Inc | 872,151 | $20.19M | 1.4% | $15.86 | — | Common | 16961L106 |
| VTYX | Ventyx Biosciences Inc | 602,075 | $20.17M | 1.4% | $18.57 | +109.4% | Common | 92332V107 |
| — | VectivBio Holding AG | 2,333,300 | $19.86M | 1.4% | $8.66 | — | Common | H9060V101 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $19.07M | 1.3% | $39.31 | -80.7% | Common | 00166B105 |
| — | Allakos Inc | 4,120,134 | $18.33M | 1.3% | $6.12 | — | Common | 01671P100 |
| ZLAB | Zai Lab Ltd ADR | 416,640 | $13.86M | 1.0% | $51.62 | — | ADR | 98887Q104 |
| LEGN | Legend Biotech Corp Sponsored | 244,375 | $11.78M | 0.8% | $42.56 | — | SPONSORED ADS | 52490G102 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $11.63M | 0.8% | $3.60 | +9.2% | Common | 20454B104 |
| — | Amyris, Inc | 7,750,828 | $10.54M | 0.7% | $3.12 | — | Common | 03236M200 |
| ACLX | Arcellx Inc. | 290,713 | $8.957M | 0.6% | $30.34 | 0.0% | Common | 03940C100 |
| — | Instil Bio Inc | 12,486,787 | $8.251M | 0.6% | $25.08 | — | Common | 45783C101 |
| — | Bellus Health Inc | 1,017,152 | $7.323M | 0.5% | $8.05 | — | Common | 07987C204 |
| ACRS | Aclaris Therapeutics, Inc. | 898,631 | $7.27M | 0.5% | $1.36 | +832.4% | Common | 00461U105 |
| SERA | Sera Prognostics Inc | 1,856,011 | $7.109M | 0.5% | $10.38 | -74.7% | Common | 81749D107 |
| KALV | KalVista Pharmaceuticals Inc. | 856,008 | $6.728M | 0.5% | $15.45 | -51.7% | Common | 483497103 |
| DYN | Dyne Therapeutics Inc | 577,642 | $6.654M | 0.5% | $20.78 | -37.5% | Common | 26818M108 |
| — | Merus NV | 353,600 | $6.506M | 0.5% | $21.00 | — | Common | N5749R100 |
| WHWK | Aadi Bioscience Inc | 509,572 | $6.456M | 0.4% | $30.48 | -64.9% | Common | 00032Q104 |
| OLMA | Olema Pharmaceuticals Inc | 1,689,515 | $5.863M | 0.4% | $39.90 | -89.8% | Common | 68062P106 |
| IOBT | IO Biotech Inc | 3,015,545 | $5.654M | 0.4% | $9.66 | -74.2% | Common | 449778109 |
| — | Bolt Therapeutics Inc | 3,871,291 | $5.381M | 0.4% | $32.91 | — | Common | 097702104 |
| — | DBV Technologies SA | 2,708,875 | $4.578M | 0.3% | $1.77 | — | Sponsored ADR | 23306J101 |
| — | Impel NeuroPharma Inc | 2,884,789 | $4.039M | 0.3% | $8.85 | — | Common | 45258K109 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $4.002M | 0.3% | $18.48 | -62.7% | Common | 462260100 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $3.49M | 0.2% | $40.33 | -22.0% | Common | 04280A100 |
| — | Aligos Therapeutics Inc | 3,547,030 | $3.1M | 0.2% | $27.65 | — | Common | 01626L105 |
| — | Gracell Biotechnologies Inc | 1,463,983 | $2.723M | 0.2% | $10.75 | — | SPONSORED ADS | 38406L103 |
| BCAB | BioAtla Inc | 637,181 | $1.708M | 0.1% | $8.30 | -56.6% | Common | 09077B104 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $1.636M | 0.1% | $3.35 | — | ADS | 04522R101 |
| CDXS | Codexis, Inc | 388,144 | $1.607M | 0.1% | $13.98 | -62.5% | Common | 192005106 |
| FULC | Fulcrum Therapeutics Inc | 550,000 | $1.567M | 0.1% | $8.96 | 0.0% | Common | 359616109 |
| IMUX | Immunic Inc | 632,184 | $942K | 0.1% | $2.73 | -31.9% | Common | 4525EP101 |
| RZLT | Rezolute Inc | 489,473 | $940K | 0.1% | $3.32 | -32.3% | Common | 76200L309 |
| — | Minerva Surgical Inc | 2,215,667 | $486K | 0.0% | $5.14 | — | Common | 60343F106 |
| — | Homology Medicines, Inc. | 370,068 | $381K | 0.0% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $106K | 0.0% | $6.03 | — | Common | 74019P108 |